The role of defensins in virus-induced asthma

David Proud1

  • 1Department of Physiology and Biophysics, HSC 1627, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta T2N 4N1, Canada. dproud @ucalgary.ca

Insights

Defensins, known antimicrobial peptides, are increasingly recognized for their role in virus-induced asthma. These molecules combat viral infections and modulate immune responses relevant to asthma development and exacerbations.

Area of Science:

  • Immunology
  • Virology
  • Pulmonology

Background:

  • Respiratory viruses are key players in asthma pathogenesis, triggering exacerbations and potentially contributing to disease development early in life.
  • Defensins, initially identified as antimicrobial peptides, possess broader functions relevant to virally induced asthma.
  • Recent research highlights the multifaceted roles of defensins beyond their antimicrobial properties.

Purpose of the Study:

  • To review recent advances in understanding the role of defensins in virus-induced asthma.
  • To explore the direct antiviral actions and immune-modulating effects of defensins.
  • To contextualize defensin functions within the pathogenesis of asthma.

Main Methods:

  • Literature review of recent studies on defensins and respiratory viral infections.
  • Analysis of defensin induction during viral infections.
  • Examination of defensin's effects on viral entry and replication.
  • Assessment of defensin's impact on innate and adaptive immunity.

Main Results:

  • Defensins are induced during viral infections and exhibit direct antiviral activity against enveloped viruses.
  • Defensins can inhibit viral infection of host cells.
  • Defensins modulate key immune cells (mast cells, epithelial cells, NK cells, dendritic cells) and influence adaptive immunity.
  • Defensins are implicated in airway remodeling processes.

Conclusions:

  • Defensins play a significant role in the context of virus-induced asthma.
  • Their antiviral, immune-modulatory, and airway remodeling effects highlight their therapeutic potential.
  • Further research into defensins could lead to novel strategies for managing virus-induced asthma.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma